Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Shares Outstanding (Weighted Average) (2020 - 2025)

IceCure Medical (ICCM) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $50.9 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 11.48% to $50.9 million in Q4 2024 year-over-year; TTM through Dec 2024 was $50.9 million, a 11.48% increase, with the full-year FY2024 number at $50.9 million, up 11.48% from a year prior.
  • Shares Outstanding (Weighted Average) was $50.9 million for Q4 2024 at IceCure Medical, up from $45.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $50.9 million in Q4 2024 to a low of $17.1 million in Q4 2020.
  • A 5-year average of $35.8 million and a median of $37.0 million in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): surged 66.67% in 2021, then grew 11.48% in 2024.
  • IceCure Medical's Shares Outstanding (Weighted Average) stood at $17.1 million in 2020, then soared by 66.67% to $28.5 million in 2021, then grew by 29.66% to $37.0 million in 2022, then grew by 23.29% to $45.6 million in 2023, then increased by 11.48% to $50.9 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Shares Outstanding (Weighted Average) are $50.9 million (Q4 2024), $45.6 million (Q4 2023), and $37.0 million (Q4 2022).